SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, View ORCID ProfileGregory Walker, Andrea Kidinger, Thomas Angelovich, Emily Waring, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Malinna Yeang, Tyra Jean, View ORCID ProfileCharles Foster, Alexandra Carey Hoppe, C. Mee Ling Munier, David Darley, Melissa Churchill, Damian Starck, Daniel Christ, Gail Matthews, View ORCID ProfileWilliam Rawlinson, Anthony D. Kelleher, Stuart Turville
doi: https://doi.org/10.1101/2022.07.07.22277128
Anupriya Aggarwal
1The Kirby Institute, University of New South Wales, New South Wales, Australia
Anouschka Akerman
1The Kirby Institute, University of New South Wales, New South Wales, Australia
Vanessa Milogiannakis
1The Kirby Institute, University of New South Wales, New South Wales, Australia
Mariana Ruiz Silva
Gregory Walker
2Serology and Virology Division (SAViD), NSW Health Pathology, Randwick, Australia
Andrea Kidinger
1The Kirby Institute, University of New South Wales, New South Wales, Australia
Thomas Angelovich
3School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia
Emily Waring
3School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia
Supavadee Amatayakul-Chantler
4Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
Nathan Roth
4Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
Germano Coppola
4Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland
Malinna Yeang
2Serology and Virology Division (SAViD), NSW Health Pathology, Randwick, Australia
Tyra Jean
2Serology and Virology Division (SAViD), NSW Health Pathology, Randwick, Australia
Charles Foster
2Serology and Virology Division (SAViD), NSW Health Pathology, Randwick, Australia
Alexandra Carey Hoppe
1The Kirby Institute, University of New South Wales, New South Wales, Australia
C. Mee Ling Munier
1The Kirby Institute, University of New South Wales, New South Wales, Australia
David Darley
5St Vincent’s Hospital, Sydney, New South Wales, Australia
Melissa Churchill
3School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia
Damian Starck
6Molecular Diagnostic Medicine Laboratory, Sydpath, St Vincent’s Hospital, Sydney, New South Wales, Australia
Daniel Christ
7Garvan Institute of Medical Research, Sydney, New South Wales, Australia
Gail Matthews
1The Kirby Institute, University of New South Wales, New South Wales, Australia
5St Vincent’s Hospital, Sydney, New South Wales, Australia
William Rawlinson
2Serology and Virology Division (SAViD), NSW Health Pathology, Randwick, Australia
Anthony D. Kelleher
1The Kirby Institute, University of New South Wales, New South Wales, Australia
5St Vincent’s Hospital, Sydney, New South Wales, Australia
Stuart Turville
1The Kirby Institute, University of New South Wales, New South Wales, Australia
Article usage
Posted July 10, 2022.
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, Gregory Walker, Andrea Kidinger, Thomas Angelovich, Emily Waring, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Malinna Yeang, Tyra Jean, Charles Foster, Alexandra Carey Hoppe, C. Mee Ling Munier, David Darley, Melissa Churchill, Damian Starck, Daniel Christ, Gail Matthews, William Rawlinson, Anthony D. Kelleher, Stuart Turville
medRxiv 2022.07.07.22277128; doi: https://doi.org/10.1101/2022.07.07.22277128
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Mariana Ruiz Silva, Gregory Walker, Andrea Kidinger, Thomas Angelovich, Emily Waring, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Malinna Yeang, Tyra Jean, Charles Foster, Alexandra Carey Hoppe, C. Mee Ling Munier, David Darley, Melissa Churchill, Damian Starck, Daniel Christ, Gail Matthews, William Rawlinson, Anthony D. Kelleher, Stuart Turville
medRxiv 2022.07.07.22277128; doi: https://doi.org/10.1101/2022.07.07.22277128
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)